United States Drugs for Vulvovaginal Candidiasis Market Report 2016

Publisher Name :
Date: 06-Oct-2016
No. of pages: 120
Inquire Before Buying

Notes:

Sales, means the sales volume of Drugs for Vulvovaginal Candidiasis

Revenue, means the sales value of Drugs for Vulvovaginal Candidiasis

This report studies sales (consumption) of Drugs for Vulvovaginal Candidiasis in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

- Bayer

- Janssen

- Viamet Pharmaceuticals

- Actavis

- Tianjin Kingyork Group

- Tianjin Pacific Pharmaceutical

- Cisen Pharmaceutical

- ...

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

- Miconazole

- Clotrimazole

- Fluconazole

Split by applications, this report focuses on sales, market share and growth rate of Drugs for Vulvovaginal Candidiasis in each application, can be divided into

- Application 1

- Application 2

- Application 3

United States Drugs for Vulvovaginal Candidiasis Market Report 2016

Table of Contents
United States Drugs for Vulvovaginal Candidiasis Market Report 2016
1 Drugs for Vulvovaginal Candidiasis Overview
1.1 Product Overview and Scope of Drugs for Vulvovaginal Candidiasis
1.2 Classification of Drugs for Vulvovaginal Candidiasis
1.2.1 Miconazole
1.2.2 Clotrimazole
1.2.3 Fluconazole
1.3 Application of Drugs for Vulvovaginal Candidiasis
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Drugs for Vulvovaginal Candidiasis (2011-2021)
1.4.1 United States Drugs for Vulvovaginal Candidiasis Sales and Growth Rate (2011-2021)
1.4.2 United States Drugs for Vulvovaginal Candidiasis Revenue and Growth Rate (2011-2021)
2 United States Drugs for Vulvovaginal Candidiasis Competition by Manufacturers
2.1 United States Drugs for Vulvovaginal Candidiasis Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Drugs for Vulvovaginal Candidiasis Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Drugs for Vulvovaginal Candidiasis Average Price by Manufactures (2015 and 2016)
2.4 Drugs for Vulvovaginal Candidiasis Market Competitive Situation and Trends
2.4.1 Drugs for Vulvovaginal Candidiasis Market Concentration Rate
2.4.2 Drugs for Vulvovaginal Candidiasis Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion
3 United States Drugs for Vulvovaginal Candidiasis Sales (Volume) and Revenue (Value) by Type (2011-2016)
3.1 United States Drugs for Vulvovaginal Candidiasis Sales and Market Share by Type (2011-2016)
3.2 United States Drugs for Vulvovaginal Candidiasis Revenue and Market Share by Type (2011-2016)
3.3 United States Drugs for Vulvovaginal Candidiasis Price by Type (2011-2016)
3.4 United States Drugs for Vulvovaginal Candidiasis Sales Growth Rate by Type (2011-2016)
4 United States Drugs for Vulvovaginal Candidiasis Sales (Volume) by Application (2011-2016)
4.1 United States Drugs for Vulvovaginal Candidiasis Sales and Market Share by Application (2011-2016)
4.2 United States Drugs for Vulvovaginal Candidiasis Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities
5 United States Drugs for Vulvovaginal Candidiasis Manufacturers Profiles/Analysis
5.1 Bayer
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Drugs for Vulvovaginal Candidiasis Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 Bayer Drugs for Vulvovaginal Candidiasis Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 Janssen
5.2.2 Drugs for Vulvovaginal Candidiasis Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 Janssen Drugs for Vulvovaginal Candidiasis Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 Viamet Pharmaceuticals
5.3.2 Drugs for Vulvovaginal Candidiasis Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 Viamet Pharmaceuticals Drugs for Vulvovaginal Candidiasis Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
5.4 Actavis
5.4.2 Drugs for Vulvovaginal Candidiasis Product Type, Application and Specification
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 Actavis Drugs for Vulvovaginal Candidiasis Sales, Revenue, Price and Gross Margin (2011-2016)
5.4.4 Main Business/Business Overview
5.5 Tianjin Kingyork Group
5.5.2 Drugs for Vulvovaginal Candidiasis Product Type, Application and Specification
5.5.2.1 Type I
5.5.2.2 Type II
5.5.3 Tianjin Kingyork Group Drugs for Vulvovaginal Candidiasis Sales, Revenue, Price and Gross Margin (2011-2016)
5.5.4 Main Business/Business Overview
5.6 Tianjin Pacific Pharmaceutical
5.6.2 Drugs for Vulvovaginal Candidiasis Product Type, Application and Specification
5.6.2.1 Type I
5.6.2.2 Type II
5.6.3 Tianjin Pacific Pharmaceutical Drugs for Vulvovaginal Candidiasis Sales, Revenue, Price and Gross Margin (2011-2016)
5.6.4 Main Business/Business Overview
5.7 Cisen Pharmaceutical
5.7.2 Drugs for Vulvovaginal Candidiasis Product Type, Application and Specification
5.7.2.1 Type I
5.7.2.2 Type II
5.7.3 Cisen Pharmaceutical Drugs for Vulvovaginal Candidiasis Sales, Revenue, Price and Gross Margin (2011-2016)
5.7.4 Main Business/Business Overview
6 Drugs for Vulvovaginal Candidiasis Manufacturing Cost Analysis
6.1 Drugs for Vulvovaginal Candidiasis Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Drugs for Vulvovaginal Candidiasis
7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Drugs for Vulvovaginal Candidiasis Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Drugs for Vulvovaginal Candidiasis Major Manufacturers in 2015
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List
9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change
10 United States Drugs for Vulvovaginal Candidiasis Market Forecast (2016-2021)
10.1 United States Drugs for Vulvovaginal Candidiasis Sales, Revenue Forecast (2016-2021)
10.2 United States Drugs for Vulvovaginal Candidiasis Sales Forecast by Type (2016-2021)
10.3 United States Drugs for Vulvovaginal Candidiasis Sales Forecast by Application (2016-2021)
10.4 Drugs for Vulvovaginal Candidiasis Price Forecast (2016-2021)
11 Research Findings and Conclusion
12 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
List of Tables and Figures
Figure Picture of Drugs for Vulvovaginal Candidiasis
Table Classification of Drugs for Vulvovaginal Candidiasis
Figure United States Sales Market Share of Drugs for Vulvovaginal Candidiasis by Type in 2015
Figure Miconazole Picture
Figure Clotrimazole Picture
Figure Fluconazole Picture
Table Application of Drugs for Vulvovaginal Candidiasis
Figure United States Sales Market Share of Drugs for Vulvovaginal Candidiasis by Application in 2015
Figure United States Drugs for Vulvovaginal Candidiasis Sales and Growth Rate (2011-2021)
Figure United States Drugs for Vulvovaginal Candidiasis Revenue and Growth Rate (2011-2021)
Table United States Drugs for Vulvovaginal Candidiasis Sales of Key Manufacturers (2015 and 2016)
Table United States Drugs for Vulvovaginal Candidiasis Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Drugs for Vulvovaginal Candidiasis Sales Share by Manufacturers
Figure 2016 Drugs for Vulvovaginal Candidiasis Sales Share by Manufacturers
Table United States Drugs for Vulvovaginal Candidiasis Revenue by Manufacturers (2015 and 2016)
Table United States Drugs for Vulvovaginal Candidiasis Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Drugs for Vulvovaginal Candidiasis Revenue Share by Manufacturers
Table 2016 United States Drugs for Vulvovaginal Candidiasis Revenue Share by Manufacturers
Table United States Market Drugs for Vulvovaginal Candidiasis Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Drugs for Vulvovaginal Candidiasis Average Price of Key Manufacturers in 2015
Figure Drugs for Vulvovaginal Candidiasis Market Share of Top 3 Manufacturers
Figure Drugs for Vulvovaginal Candidiasis Market Share of Top 5 Manufacturers
Table United States Drugs for Vulvovaginal Candidiasis Sales by Type (2011-2016)
Table United States Drugs for Vulvovaginal Candidiasis Sales Share by Type (2011-2016)
Figure United States Drugs for Vulvovaginal Candidiasis Sales Market Share by Type in 2015
Table United States Drugs for Vulvovaginal Candidiasis Revenue and Market Share by Type (2011-2016)
Table United States Drugs for Vulvovaginal Candidiasis Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Drugs for Vulvovaginal Candidiasis by Type (2011-2016)
Table United States Drugs for Vulvovaginal Candidiasis Price by Type (2011-2016)
Figure United States Drugs for Vulvovaginal Candidiasis Sales Growth Rate by Type (2011-2016)
Table United States Drugs for Vulvovaginal Candidiasis Sales by Application (2011-2016)
Table United States Drugs for Vulvovaginal Candidiasis Sales Market Share by Application (2011-2016)
Figure United States Drugs for Vulvovaginal Candidiasis Sales Market Share by Application in 2015
Table United States Drugs for Vulvovaginal Candidiasis Sales Growth Rate by Application (2011-2016)
Figure United States Drugs for Vulvovaginal Candidiasis Sales Growth Rate by Application (2011-2016)
Table Bayer Basic Information List
Table Bayer Drugs for Vulvovaginal Candidiasis Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Bayer Drugs for Vulvovaginal Candidiasis Sales Market Share (2011-2016)
Table Janssen Basic Information List
Table Janssen Drugs for Vulvovaginal Candidiasis Sales, Revenue, Price and Gross Margin (2011-2016)
Table Janssen Drugs for Vulvovaginal Candidiasis Sales Market Share (2011-2016)
Table Viamet Pharmaceuticals Basic Information List
Table Viamet Pharmaceuticals Drugs for Vulvovaginal Candidiasis Sales, Revenue, Price and Gross Margin (2011-2016)
Table Viamet Pharmaceuticals Drugs for Vulvovaginal Candidiasis Sales Market Share (2011-2016)
Table Actavis Basic Information List
Table Actavis Drugs for Vulvovaginal Candidiasis Sales, Revenue, Price and Gross Margin (2011-2016)
Table Actavis Drugs for Vulvovaginal Candidiasis Sales Market Share (2011-2016)
Table Tianjin Kingyork Group Basic Information List
Table Tianjin Kingyork Group Drugs for Vulvovaginal Candidiasis Sales, Revenue, Price and Gross Margin (2011-2016)
Table Tianjin Kingyork Group Drugs for Vulvovaginal Candidiasis Sales Market Share (2011-2016)
Table Tianjin Pacific Pharmaceutical Basic Information List
Table Tianjin Pacific Pharmaceutical Drugs for Vulvovaginal Candidiasis Sales, Revenue, Price and Gross Margin (2011-2016)
Table Tianjin Pacific Pharmaceutical Drugs for Vulvovaginal Candidiasis Sales Market Share (2011-2016)
Table Cisen Pharmaceutical Basic Information List
Table Cisen Pharmaceutical Drugs for Vulvovaginal Candidiasis Sales, Revenue, Price and Gross Margin (2011-2016)
Table Cisen Pharmaceutical Drugs for Vulvovaginal Candidiasis Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Drugs for Vulvovaginal Candidiasis
Figure Manufacturing Process Analysis of Drugs for Vulvovaginal Candidiasis
Figure Drugs for Vulvovaginal Candidiasis Industrial Chain Analysis
Table Raw Materials Sources of Drugs for Vulvovaginal Candidiasis Major Manufacturers in 2015
Table Major Buyers of Drugs for Vulvovaginal Candidiasis
Table Distributors/Traders List
Figure United States Drugs for Vulvovaginal Candidiasis Production and Growth Rate Forecast (2016-2021)
Figure United States Drugs for Vulvovaginal Candidiasis Revenue and Growth Rate Forecast (2016-2021)
Table United States Drugs for Vulvovaginal Candidiasis Production Forecast by Type (2016-2021)
Table United States Drugs for Vulvovaginal Candidiasis Consumption Forecast by Application (2016-2021)
  • Global Physiotherapy Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 16-Jan-2019        Price: US 3480 Onwards        Pages: 120
    Physiotherapy is a nonsurgical treatment method, where the treatment for impairments such as injury, deformity. Scope of the Report: This report focuses on the Physiotherapy in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. The increasing use of portable physiotherapy equipment in sports will drive the growth prospects......
  • Global Colloids (Blood Plasma) Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 16-Jan-2019        Price: US 3480 Onwards        Pages: 138
    Colloids (blood plasma) are the substances of expanding the circulating blood volume, which mainly contain albumin type, gelatin type, dextran type and hydroxyethyl starch type. Colloids (Blood Plasma) can be applied for extensive burns, massive blood or plasma loss and hypovolemic shock. In this report, we calculate colloids (blood plasma) preparations, which is produced by albumin, gelatin, dextran and hydroxyethyl starch. Scope of the Report: This report focuses o......
  • Global Plasma Therapeutics Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 16-Jan-2019        Price: US 3480 Onwards        Pages: 116
    Plasma, pale yellow in color, is the component of the blood. Scope of the Report: This report focuses on the Plasma Therapeutics in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. To calculate the market size, the report considers revenue generated from the sales of branded therapies derived from the various fractions o......
  • Global Physiological Sea Water Nasal Spray Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 16-Jan-2019        Price: US 3480 Onwards        Pages: 121
    This report mainly analyzed Physiological Sea Water Nasal Spray Sales status. Physiological Sea Water Nasal Spray is collection of sea water. Physiological Sea Water Nasal Spray is suitable for infants, children and adults for the daily cleaning of the nasal cavity, and it can provide protection for nasal mucosa against allergens, dry air, pollutants. Scope of the Report: This report focuses on the Physiological Sea Water Nasal Spray in global market, especially in N......
  • Global Gastrointestinal Therapeutics and Diagnostics Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 16-Jan-2019        Price: US 3480 Onwards        Pages: 117
    Gastrointestinal disorders are related to digestive system and generally affect the colon, small & large intestine and rectum. The disorders include constipation, peptic ulcer diseases and irritable bowel syndrome. The major reason and cause of GI disorders are stress, intake of medicines such as iron pills and anti-depressants and unhealthy eating habits. Symptoms of the gastrointestinal infections include pain, bloating, diarrhea, nausea and vomiting. The major drugs that dominate the gastroin......
  • Global Hormone Refractory Prostate Cancer (HRPCA) Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 16-Jan-2019        Price: US 3480 Onwards        Pages: 102
    Hormone Refractory Prostate Cancer (HRPCA) or Castrate-Resistant Prostate Cancer (CRPC), a type of prostate cancer that typically recurs after having hormonal therapy, is now under the spotlight in prostate cancer market. Due to the high unmet clinical need associated with limited survival periods, intensifying HRPCA prevalence and fast-emerging treatment modifications, the global HRPCA market is poised to witness an unprecedented growth. Scope of the Report: This report fo......
  • Global Gastrointestinal Cancer Drugs Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 16-Jan-2019        Price: US 3480 Onwards        Pages: 116
    Gastrointestinal cancer is the abnormal condition of the gastrointestinal tract and associated organs of digestive system, which comprises esophagus, stomach, pancreas, biliary system, small intestine, large intestine, rectum, and anus. The symptoms of gastrointestinal cancer depend on the affected organ, and include obstruction (resulting in difficulty to swallow or excrete), unusual bleeding, or other related problems. Scope of the Report: This report focuses on the Gastr......
  • Global Herbal Medicines Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 16-Jan-2019        Price: US 3480 Onwards        Pages: 135
    Herbal medicine, or phytomedicine is a medicinal system using a plant or animal materials such as seeds, roots, leaves, bark, flowers, oils etc. for medicinal purposes. Scope of the Report: This report focuses on the Herbal Medicines in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. The worldwide market for Herbal Med......
  • Global Hereceptin Biosimilars Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 16-Jan-2019        Price: US 3480 Onwards        Pages: 119
    Herceptin, also known as trastuzumab, is used as a medication for patients who suffer from cancer, which assists in controlling the growth and spread of cancer cells in the body. Herceptin biosimilars are essentially used to treat certain breast as well stomach cancers, and is also used in combination with other medicines for treatment. Scope of the Report: This report focuses on the Hereceptin Biosimilars in global market, especially in North America, Europe and Asia-Pacif......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs